Response to eLetter: 'Discussion of methotrexate dosage' by Maguire <i>et al</i>.

Safy, Mary; Jacobs, J W G; Ijff, Nicole D; Bijlsma, J W J; van Laar, J M; de Hair, Maria J H

Response to eLetter: 'Discussion of methotrexate dosage' by Maguire et al.

Safy, Mary; Jacobs, J W G; Ijff, Nicole D; Bijlsma, J W J; van Laar, J M; de Hair, Maria J H.

Afiliación

Safy M; Department of Rheumatology and Clinical Immunology, University Medical Center, Utrecht, the Netherlands.
Jacobs JWG; Department of Rheumatology and Clinical Immunology, University Medical Center, Utrecht, the Netherlands.
Ijff ND; Department of Rheumatology and Clinical Immunology, University Medical Center, Utrecht, the Netherlands.
Bijlsma JWJ; Department of Rheumatology and Clinical Immunology, University Medical Center, Utrecht, the Netherlands.
van Laar JM; Department of Rheumatology and Clinical Immunology, University Medical Center, Utrecht, the Netherlands.
de Hair MJH; Department of Rheumatology and Clinical Immunology, University Medical Center, Utrecht, the Netherlands.

Ann Rheum Dis ; 77(8): e48, 2018 08.

Article en En | MEDLINE | ID: mdl-28993345

Asunto(s)

Artritis Reumatoide; Metotrexato; Estudios de Seguimiento; Humanos; Prednisona

Palabras clave

disease activity; methotrexate; treatment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Reumatoide / Metotrexato Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google